Editorial

Jan F. Vojáček

Interv Akut Kardiol. 2020;19(3):147-148 | DOI: 10.36290/kar.2020.037  

The use of T-MACS algorithm in elderly patients in acute cardiac care

Juraj Hrečko, Jiří Dokoupil, Radek Pudil

Interv Akut Kardiol. 2020;19(3):149-154 | DOI: 10.36290/kar.2020.038  

Introduction: Chest pain is one of the leading causes for visit at the emergency department. Atypical symptoms, ambiguous laboratory and electrocardiographical findings in elderly make the rapid diagnostics difficult. Diagnostic algorithms were developed for effective risk stratification and they can direct us towards the right diagnosis and correct treatment. Objective: The aim of this study is to evaluate the effectiveness of T-MACS algorithm in very old patients presenting with acute chest pain. Methods: Retrospective analysis of 104 patients older than 80 years which were examined at emergency department for acute chest pain. Primary composite...

Optimal pharmacotherapy following percutaneous coronary intervention for chronic coronary artery disease

Pavel Červinka

Interv Akut Kardiol. 2020;19(3):156-160 | DOI: 10.36290/kar.2020.009  

Cardiovascular diseases are responsible for the majority of deaths in the developed countries as well as in the Czech Republic. Pharmacotherapy after PCI in patients with chronic CAD must be tailored to the individual patient with respect to patient characteristics (age, history of MI, presence of other risk factors, etc.), coronary involvement and systolic function of the left ventricle (single versus multivessel disease, completeness of revascularization, preserved or depressed left ventricular systolic function), and with respect to the percutaneous procedure itself (number of stents, bare versus drug-eluting stents, bifurcation stenosis, left main...

Initial dose of acetylsalicylic acid and heparin in a patient with STEMI

Jiří Knot, Zuzana Moťovská

Interv Akut Kardiol. 2020;19(3):163-165 | DOI: 10.36290/kar.2020.039  

Acute myocardial infarction most commonly occurs as a result of a thrombotic occlusion of a coronary artery that originates as a consequence of an unstable atherosclerotic plaque rupture. Early reperfusion of the infarct related artery is a crucial factor in treating patients with myocardial infarction. For this purpose, primary percutaneous coronary intervention is currently performed. In a small proportion of patients meeting the indication criteria, it is possible to administer thrombolytic therapy. Antithrombotic therapy is a part of both these above-mentioned reperfusion modalities. Acetylsalicylic acid has long been the mainstay of treatment...

What is the role of ICD implantation in primary prevention of sudden cardiac death in the current population of patients with heart failure?

Tomáš Roubíček, Rostislav Polášek

Interv Akut Kardiol. 2020;19(3):166-169 | DOI: 10.36290/kar.2020.008  

Chronic heart failure in patients with left ventricular systolic dysfunction is a serious disease with an increasing prevalence in the population. This group of patients is at risk of developing severe ventricular arrhythmias with a risk of sudden death. Implantation of a cardioverter-defibrillator in primary prevention of sudden cardiac death is an established practice in this group of patients. However, since nearly 20 years have passed since the publication of significant clinical studies on which ICD implantation recommendations are based, it could appear that these studies may be outdated. The latest findings are discussed in this review article....

Epicardial mapping and ablation via a subxiphoid percutaneous approach

Petr Peichl, Josef Kautzner

Interv Akut Kardiol. 2020;19(3):170-175 | DOI: 10.36290/kar.2020.010  

Catheter ablation is an effective method for the treatment of cardiac arrhythmias. In some patients, the arrhythmogenic substrate can be located on the epicardial aspect of the cardiac chambers and may be inaccessible from the endocardium. Therefore, percutaneous epicardial access to the pericardium has been introduced. Currently, it is used for patients in whom endocardial ablation has failed or in whom imaging studies or ECG characteristics suggest the presence of an epicardial substrate. Other indications include specific myocardial diseases, such as arrhythmogenic cardiomyopathy and Brugada syndrome. The aim of our paper is to review current techniques...

COSYREL® - one fixed combination, multiple use in treatment

Zdeněk Coufal

Interv Akut Kardiol. 2020;19(3):176-178 | DOI: 10.36290/kar.2020.035  

ACE inhibitors and beta-blocking agents have an irreplaceable role in various indications in cardiology, including hypertension, heart failure, secondary prevention in coronary heart disease, especially after acute coronary syndromes. They can be successfully used in other indications, too. Patient prognosis can be influenced at various levels, which however means higher numbers of drugs used. In recent years, we have witnessed trends in drug manufacturers to bring to the market pills with two or three complementary substances. One of them - a fixed combination of a beta-blocking agent and an ACE inhibitor - is unique and its name is COSYREL®.

Blunt chest trauma as a cause of acute myocardial infarction

Vladimír Rozsíval, Tomáš Lazarák, Vojtěch Novotný, Milan Plíva, David Vindiš, Ivo Varvařovský

Interv Akut Kardiol. 2020;19(3):179-181 | DOI: 10.36290/kar.2020.011  

A case of post-traumatic coronary injury presenting with coronary occlusion and myocardial infarction is described. A 50-years-old man sustained a blunt chest trauma a three years ago. Myocardial infarction was not recognised, because chest pain was attributed to (and masked by) rib injury. Coronary angiography was indicated based on an incidental abnormal ECG finding during a preventive examination.

Kontroverze - aspirin po PCI?Aspirin po PCI: proč nepodávat

Ivo Varvařovský

Interv Akut Kardiol. 2020;19(3):182-183 | DOI: 10.36290/kar.2020.040  

Kontroverze - aspirin po PCI?Aspirin po PCI: proč podávat

Jan F. Vojáček

Interv Akut Kardiol. 2020;19(3):184-186 | DOI: 10.36290/kar.2020.041  

Je koronarografie vhodná u všech nemocných s bolestí na hrudi a zvýšeným troponinem?

Tomáš Janota

Interv Akut Kardiol. 2020;19(3):188-190 | DOI: 10.36290/kar.2020.043  

MUDr. Michael Želízko, CSc., se v letošním roce dožívá 60 let

prof. MUDr. Jan Vojáček, DrSc., FESC, FACC

Interv Akut Kardiol. 2020;19(3):187 | DOI: 10.36290/kar.2020.042